These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients. Colombini E, Guzzo I, Morolli F, Longo G, Russo C, Lombardi A, Merli P, Barzon L, Murer L, Piga S, Ciofi Degli Atti ML, Locatelli F, Dello Strologo L. Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938 [Abstract] [Full Text] [Related]
29. Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study. Walti LN, Mugglin C, Sidler D, Mombelli M, Manuel O, Hirsch HH, Khanna N, Mueller N, Berger C, Boggian K, Garzoni C, Neofytos D, van Delden C, Hirzel C, Swiss Transplant Cohort Study (STCS)Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.. Am J Transplant; 2021 Jul; 21(7):2532-2542. PubMed ID: 33289340 [Abstract] [Full Text] [Related]